RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

80 hedge funds and large institutions have $301M invested in Revance Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$20.1M
2 +$5.2M
3 +$2.95M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$2.74M
5
JP Morgan Chase
JP Morgan Chase
New York
+$2.23M

Top Sellers

1 -$21.4M
2 -$15.9M
3 -$12.3M
4
DM
Deerfield Management
New York
-$8.72M
5
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
-$4.42M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$307K
52
$305K
53
$279K
54
$204K
55
$203K
56
$203K
57
$193K
58
$172K
59
$140K
60
$116K
61
$115K
62
$95K
63
$87.9K
64
$48K
65
$39K
66
$36K
67
$30K
68
$26K
69
$19K
70
$19K
71
$13K
72
$12K
73
$9K
74
$7.89K
75
$6K